Can-Fite BioPharma Ltd. buy Lokrim
Start price
22.02.21
/
20%
€21.80
Target price
22.02.22
-
Performance (%)
-46.79%
End price
14.11.21
€11.60
Summary
This prediction ended on 14.11.21 with a price of €11.60. Massive losses of -46.79% were the result for the BUY prediction by Lokrim. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Can-Fite BioPharma Ltd. | - | - | - | - |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % | 44,61 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % | 70,74 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % | 48,21 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % | 54,25 % |
According to Lokrim what are the pros and cons of Can-Fite BioPharma Ltd. for the foreseeable future?
Pros
Cons
Probably not worthwhile Investment
Comments by Lokrim for this prediction
In the thread Can-fite Biopharma Ltd. diskutieren
Buy Can-fite Biopharma Ltd.
In the thread Trading Can-fite Biopharma Ltd.
Stopped prediction by Lokrim for Can-Fite BioPharma Ltd.
Can-Fite BioPharma Ltd.
Start price
Target price
Perf. (%)
€11.60
14.11.21
14.11.21
-
14.11.22
14.11.22
-33.62%
15.11.22
15.11.22
Probably not worthwhile Investment
